All News

Weekly mobile phone text messaging may help patients with human immunodeficiency virus adhere to antiretroviral therapy that is often associated with difficult side effects, according to a study published online March 14 in the Cochrane Database of Systematic Reviews.

Daily supplementation with antioxidants, vitamins E and C, and alpha acid, did not improve memory function in patients with Alzheimer?s disease, according to a new study.

Aspirin can reduce the risk for cancer-related mortality and can reduce or prevent the risk for distant metastasis, according to 3 new studies published online by The Lancet and The Lancet Oncology.

Enhanced pharmacist care for patients with dyslipidemia improves low-density lipoprotein cholesterol levels, according to a study published in the March issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.

Express Scripts and Medco Health Solutions may be able to close the transaction of its merger as early as next week, according to an announcement Wednesday by Express Scripts.

FDA added new label warnings for the antidepressant citalopram (Celexa, Forest Laboratories), discouraging patients with certain conditions from using the drug and lowering the dosage recommendations to 20 mg daily for patients aged 60 and older. The warning is also applicable to generic versions of Celexa.

FDA has approved peginesatide (Omontys, Affymax) to treat anemia in adult dialysis patients who have chronic kidney disease (CKD).

Pharmacists and pharmacy advocates conducted more than 350 meetings with U.S. senators and representatives on Capitol Hill last week during RxIMPACT Day, sponsored by the National Association of Community Drug Stores.

A New York community pharmacist highlighted the problem of mail-order waste after a man turned in $30,000 worth of medications to the pharmacy.

A bi-partisan bill that would extend anti-trust immunity to independent pharmacies is slated for hearings before the House Judiciary Committee in Washington, D.C., later this week.

The American Pharmacists Association and the National Community Pharmacists Association supported a new nonprescription class of drugs at FDA?s public hearing last week.

FDA has approved beclomethasone dipropionate (QNASL Nasal Aerosol, Teva Pharmaceutical Industries), a ?dry? nasal aerosol corticosteroid that treats year-round and seasonal nasal allergy symptoms in people aged 12 years and older.

Amneal Pharmaceuticals has launched Escitalopram Oxalate Oral Solution in 5-mg/5-mL strength, the first generic of antianxiety/antidepressant Lexapro (Forest) in liquid form on the market. .

The majority of older women in nursing homes are likely to be deficient in vitamin D during winter months, and those with the lowest levels are at a significantly increased risk of death, according to a study published online February 8, in the Journal of Clinical Endocrinology

As pharmacy transforms into a patient-care model, everyone must "do what is needed to make a difference," Jenelle L. Sobotka, Ohio Northern University Raabe College of Pharmacy professor, said after she was sworn in as president of the American Pharmacists Association at its annual conference in New Orleans this month.

Ingenol mebutate topical gel (0.015% for face and scalp and 0.05% for trunk and extremities) was effective for treating actinic keratoses, a common precursor to sun-related, squamos-cell carcinoma, according to a new study.

Diacetylmorphine, or heroin, may be a more effective, cheaper treatment than methadone for people with relapsing chronic opioid dependence, according to a study published in the Canadian Medical Association Journal.

A new study of patients with moderate to severe Alzheimer's disease found that extended treatment with donepezil could improve cognition and function for even severe patients; however, experts caution that the benefits of the drug were modest

Clinical pharmacists were instrumental in reducing errors in patients' physician-acquired medication histories, according to a study published online on March 13 in the Annals of Pharmacotherapy.

The Affordable Care Act (ACA) continues to close the “donut hole” coverage gap for millions of Medicare beneficiaries, Kathleen Sebelius, Secretary of Health and Human Services, said in a news release Monday, saving them more than $3.2 billion on prescription drugs since the ACA took effect almost 2 years ago.

Drug Topics ranked No. 1 among professional journals on the reading list of pharmacists, according to a survey recently released by Long Island University.

New programs and recognitions make 2012 a great year for community pharmacies to be more involved in medication therapy management, according to a speaker at the FMI Health & Wellness Conference in Orlando, Fla., this week.

What’s different in your drug stores this month? Your customers who are allergic to antibiotic ointments and creams will find a new first aid gel that’s antibiotic-free. There’s a prenatal dietary supplement with 450 mg of DHA. Men can check their sperm count at home with a new 10-minute tes,t and women will find a laxative that’s made just for them. A familiar brand of mouthwash has been made even stronger. And a new dipeptide product supports healthy aging.

Pharmacists and dietitians are playing important roles in the new health-and-wellness program at United Supermarkets, a chain of 51 stores in Lubbock, Texas.

J. Lyle Bootman, PhD, ScD, senior vice president for Health Sciences, dean and professor of Pharmacy, Medicine, and Public Health, University of Arizona, College of Pharmacy, was honored as the PPSI Distinguished Pharmacist of the Year, during PPSI’s annual breakfast, held during the American Pharmacists Association 2012 annual meeting in New Orleans.

FDA approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.

The final rule for Medicaid eligibility in the Affordable Care Act (ACA) will ensure health coverage for millions of Americans, according to Friday's announcement by Health and Human Services Secretary Kathleen Sebelius.

FDA has approved a new indication for estradiol valerate and estradiol valerate/dienogest (Natazia, Bayer HealthCare Pharmaceuticals) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus.